Recent Articles
Posted By: Michael C. Soulen, MD
Thu Feb 16th, 2017
Optimal patient care is no longer the province of solitary specialists; rather it is provided by multidisciplinary care teams. This has lead to the genesis of diseased-centered subspecialty societies
Posted By: Michael C. Soulen, MD
Sat Jan 25th, 2014
I just finished reviewing my assigned batch of the hundreds of abstracts submitted to WCIO for our 10th annual scientific meeting in New York May 11-14, and what an exciting bunch they were! The amount of innovation in the field of IO is astounding.
Posted By: Michael C. Soulen, MD
Sun Jan 12th, 2014
The start of a new year is a great time to look back and forwards. WCIO made the leap from a freestanding annual scientific congress to become the world community for IO in 2010. We quickly launched IO Central, the global on-line open-membership forum for IO...
Posted By: Erica Lucca
Mon Jun 10th, 2013
Researchers in a new study sought to report 10-year outcomes of treating hepatocellular carcinomas (HCCs) by combination therapy of chemoembolization and radiofrequency (RF) ablation. Combination therapy was administered in 277 patients with 382 treatment-naïve HCCs. Therapeutic effects, safety, sur
Posted By: Erica Lucca
Mon Jun 10th, 2013
Researchers in Japan conducted a study to evaluate whether antitumor immunity is enhanced systemically by combining radiofrequency ablation (RFA) and local injection of an immunostimulant, OK-432. Rabbits were inoculated with VX2 tumors in the lung and the auricle were randomized into four groups of
